These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17577685)

  • 1. Aggregation drives "misfolding" in protein amyloid fiber formation.
    Xu S
    Amyloid; 2007 Jun; 14(2):119-31. PubMed ID: 17577685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replica exchange molecular dynamics simulations of amyloid peptide aggregation.
    Cecchini M; Rao F; Seeber M; Caflisch A
    J Chem Phys; 2004 Dec; 121(21):10748-56. PubMed ID: 15549960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-beta-sheet structure in amyloid fiber formation.
    Xu S
    J Phys Chem B; 2009 Sep; 113(37):12447-55. PubMed ID: 19705845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates.
    Cerdà-Costa N; Esteras-Chopo A; Avilés FX; Serrano L; Villegas V
    J Mol Biol; 2007 Mar; 366(4):1351-63. PubMed ID: 17204287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-folding and aggregation of amyloid nanofibrils.
    Paparcone R; Cranford SW; Buehler MJ
    Nanoscale; 2011 Apr; 3(4):1748-55. PubMed ID: 21347488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-specific effects of protein topology on cross-beta assembly: studies of insulin fibrillation.
    Huang K; Maiti NC; Phillips NB; Carey PR; Weiss MA
    Biochemistry; 2006 Aug; 45(34):10278-93. PubMed ID: 16922503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
    FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dead-end street of protein folding: thermodynamic rationale of amyloid fibril formation.
    Perczel A; Hudáky P; Pálfi VK
    J Am Chem Soc; 2007 Dec; 129(48):14959-65. PubMed ID: 17997554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A native to amyloidogenic transition regulated by a backbone trigger.
    Eakin CM; Berman AJ; Miranker AD
    Nat Struct Mol Biol; 2006 Mar; 13(3):202-8. PubMed ID: 16491088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of model systems for amyloid formation: lessons for prediction and inhibition.
    Pastor MT; Esteras-Chopo A; López de la Paz M
    Curr Opin Struct Biol; 2005 Feb; 15(1):57-63. PubMed ID: 15718134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solvational tuning of the unfolding, aggregation and amyloidogenesis of insulin.
    Grudzielanek S; Jansen R; Winter R
    J Mol Biol; 2005 Aug; 351(4):879-94. PubMed ID: 16051271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and promotion effects of apolipoprotein E4 on amylin aggregation.
    Lei P; Wu WH; Li RW; Ma JW; Yu YP; Cui W; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2008 Apr; 368(2):414-8. PubMed ID: 18243137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-strand pairing and amyloid assembly.
    Liang Y; Pingali SV; Jogalekar AS; Snyder JP; Thiyagarajan P; Lynn DG
    Biochemistry; 2008 Sep; 47(38):10018-26. PubMed ID: 18759497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation.
    Esteras-Chopo A; Morra G; Moroni E; Serrano L; Lopez de la Paz M; Colombo G
    J Mol Biol; 2008 Oct; 383(1):266-80. PubMed ID: 18703072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of beta-sheet propensity on peptide aggregation.
    Bellesia G; Shea JE
    J Chem Phys; 2009 Apr; 130(14):145103. PubMed ID: 19368476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature.
    Wang L; Lashuel HA; Colón W
    Amyloid; 2005 Sep; 12(3):139-48. PubMed ID: 16194868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of soluble amyloid oligomers from computer simulations.
    Melquiond A; Mousseau N; Derreumaux P
    Proteins; 2006 Oct; 65(1):180-91. PubMed ID: 16894607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards gelsolin amyloid formation.
    Liepina I; Janmey P; Czaplewski C; Liwo A
    Biopolymers; 2004; 76(6):543-8. PubMed ID: 15538717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What the use of disease-unrelated model proteins can tell us about the molecular basis of amyloid aggregation and toxicity.
    Stefani M
    Ital J Biochem; 2003 Dec; 52(4):162-76. PubMed ID: 15141483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Length dependence of the coil <--> beta-sheet transition in a membrane environment.
    Meier M; Seelig J
    J Am Chem Soc; 2008 Jan; 130(3):1017-24. PubMed ID: 18163629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.